Risk of atrial fibrillation with use of oral and intravenous bisphosphonates.
Sharma A, Einstein AJ, Vallakati A, Arbab-Zadeh A, Walker MD, Mukherjee D, Homel P, Borer JS, Lichstein E.
Sharma A, et al. Among authors: lichstein e.
Am J Cardiol. 2014 Jun 1;113(11):1815-21. doi: 10.1016/j.amjcard.2014.03.008. Epub 2014 Mar 15.
Am J Cardiol. 2014.
PMID: 24837258
Review.